首页|84例接骨七厘制剂不良反应分析与管理建议

84例接骨七厘制剂不良反应分析与管理建议

扫码查看
目的:分析接骨七厘制剂的药品不良反应(ADR)发生特征,为其安全合理用药提供参考.方法:收集2010年1月1日~2022年12月6日期间国家药品不良反应监测系统中有关接骨七厘制剂的ADR报告,采用回顾性研究方法对患者性别、年龄、用药原因、严重ADR报告、ADR累及系统/器官及主要临床表现、合并用药进行统计分析.结果:共收集了84例ADR报告,其中男性患者略多于女性患者,患者年龄多分布在45~64岁(36.90%),主要用药原因为骨折(51.19%),有11例严重ADR报告,ADR累及系统/器官主要为胃肠系统疾病(61.15%),与活血止痛胶囊联用时出现的ADR较多.结论:在临床使用中应当加强接骨七厘制剂ADR监测,确保患者用药合理安全.
Analysis and Management Suggestions of 84 Cases of Adverse Reactions of Jiegu Qili Preparation
Objective:To analyze the pattern of adverse drug reaction(ADR)of Jiegu Qili preparation,providing a reference for safe and rational drug use.Methods:The ADR reports of Jiegu Qili preparation from January 1,2010 to December 6,2022 in the National Adverse Drug Reaction Monitoring System were collected.The gender,age,medication reasons,serious ADR reports,ADR involving system/organ and main clinical manifestations,and concomitant medications were statistically analyzed by a retrospective study.Results:A total of 84 cases of ADR were collected.Male patients were slightly more than female patients,and the age of patients was mainly distributed in 45~64 years old(36.90%).The main reason for medication was fracture(51.19%).There were 11 cases of serious ADR reported,and the ADR involving system/organ were mainly gastrointestinal disorders(61.15%),with an increase in ADR when combined with Huoxue Zhitong capsules.Conclusion:The monitoring of ADR associated with Jiegu Qili preparation in clinical application should be strengthened to ensure the safe and rational drug use for patients.

Jiegu Qili preparationadverse drug reactionrational drug useadverse drug reaction monitoringanalysis

龙慧玲、贺先琳

展开 >

湖南省药品审评与不良反应监测中心,长沙 410013

湖南省药品审核查验中心,长沙 410001

接骨七厘制剂 药品不良反应 合理用药 不良反应监测 分析

2024

中国合理用药探索
中国执业药师协会

中国合理用药探索

影响因子:0.62
ISSN:2096-3327
年,卷(期):2024.21(7)